Cargando…
Role of almitrine bismesylate in managing refractory hypoxemia in COVID19 acute respiratory distress syndrome
Autores principales: | Nair, Abhijit S., Pulipaka, Sai Kaushik, Anne, Poornachand, Rayani, Basanth Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016063/ https://www.ncbi.nlm.nih.gov/pubmed/33824652 http://dx.doi.org/10.4103/sja.SJA_782_20 |
Ejemplares similares
-
Cebranopadol: A First-in-Class Nociceptin Receptor Agonist for Managing Chronic Pain
por: Nair, Abhijit S, et al.
Publicado: (2020) -
Effect of almitrine bismesylate and inhaled nitric oxide on oxygenation in COVID-19 acute respiratory distress syndrome
por: Cardinale, Michael, et al.
Publicado: (2020) -
Innovative Method to Deal with Pericatheter Leak in Home-based Management of Malignant Ascites
por: Suvvari, Praneeth, et al.
Publicado: (2020) -
Efficacy of Almitrine in the Treatment of Hypoxemia in Sars-Cov-2 Acute Respiratory Distress Syndrome
por: Barthélémy, Romain, et al.
Publicado: (2020) -
Acute gastric conduit dilatation after oesophagectomy as a cause of respiratory distress
por: Nair, Abhijit S, et al.
Publicado: (2018)